Inventor · disambiguated record
Sham Nikam
Also filed as: NIKAM SHAM · NIKAM SHAM S · NIKAM SHAM SHRIDHAR
27 granted patents·2 pending applications·100 citations·filing 1994–2018
95Inventor score
Top patents by PatentIndex Score
29 records- 0180US6121488AQuenching reagents for solution phase synthesisWARNER LAMBERT CO·Filed 1998·Granted Sep 19, 2000·17 cites·10 claims
- 0276US5658902AQuinazolines as inhibitors of endothelin converting enzymeWARNER LAMBERT CO·Filed 1994·Granted Aug 19, 1997·16 cites·13 claims
- 0366US6096744ASulfonamide derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonistsWARNER LAMBERT CO·Filed 1998·Granted Aug 1, 2000·11 cites·3 claims
- 0465US6765022B2Cyclohexylamine derivatives as subtype selective nmda receptor antagonistsWARNER LAMBERT CO·Filed 2001·Granted Jul 20, 2004·2 cites·7 claims
- 0563US6642256B2Piperidine derivatives as subtype selective N-Methyl-D-Aspartate antagonistsWARNER LAMBERT CO·Filed 2001·Granted Nov 4, 2003·2 cites·8 claims
- 0663US6340758B1Conformationally semi-constrained quinoxaline 2,3-diones as neuroprotective agentsWARNER LAMBERT CO·Filed 1998·Granted Jan 22, 2002·8 cites·2 claims
- 0762US6794402B2Bicyclic cyclohexylamines and their use as NMDA receptor antagonistsWARNER LAMBERT CO·Filed 2001·Granted Sep 21, 2004·1 cites·12 claims
- 0858US11690839B2Treatment of idiopathic pulmonary fibrosisTAKEDA GMBH·Filed 2018·Granted Jul 4, 2023·0 cites·11 claims
- 0957US7101886B2Phenylalkyl and pyridylalkyl piperazine derivativesWARNER LAMBERT CO·Filed 2003·Granted Sep 5, 2006·1 cites·14 claims
- 1056US6015800ASubstituted quinoxaline-2-ones as glutamate receptor antagonistsWARNER LAMBERT CO·Filed 1998·Granted Jan 18, 2000·6 cites·4 claims
- 1154US5773444AQuinazolines as inhibitors of endothelin converting enzymeWARNER LAMBERT CO·Filed 1997·Granted Jun 30, 1998·5 cites·5 claims
- 1253US5663296AHydroxamate inhibitors of endothelin converting enzymeWARNER LAMBERT CO·Filed 1995·Granted Sep 2, 1997·7 cites·11 claims
- 1348US6455698B1Conformationally semi-constrained quinoxaline 2,3-diones as neuroprotective agentsWARNER LAMBERT CO·Filed 2001·Granted Sep 24, 2002·0 cites·2 claims
- 1448US5654303AAlkyl amine derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonistsWARNER LAMBERT CO·Filed 1995·Granted Aug 5, 1997·8 cites·15 claims
- 1547US5614508AAmino acid derivatives of substituted quinoxaline 2,3-dione derivatives as glutamate receptor antagonistsWARNER LAMBERT CO·Filed 1995·Granted Mar 25, 1997·7 cites·14 claims
- 1646US6268366B1Amide derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonistsWARNER LAMBERT CO·Filed 2000·Granted Jul 31, 2001·0 cites·2 claims
- 1746US6172065B1Urea and thiourea derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonistsWARNER LAMBERT CO·Filed 1997·Granted Jan 9, 2001·3 cites·9 claims
- 1846US2005282819A1Heterocyclic substituted indane derivatives and related compounds for the treatment of schizophreniaGRAHAM JAMES M·Filed 2004·Application pending·0 cites
- 1944US6417396B1Quenching reagents for solution phase synthesisWARNER LAMBERT CO·Filed 2000·Granted Jul 9, 2002·0 cites·10 claims
- 2041US6828341B2Cyclohexylamine derivatives as subtype selective N-Methyl-D-Aspartate antagonistsWARNER LAMBERT CO·Filed 2002·Granted Dec 7, 2004·0 cites·10 claims
- 2141US5874426ACyclic amine derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonistsWARNER LAMBERT CO·Filed 1995·Granted Feb 23, 1999·4 cites·9 claims
- 2240US6683101B2Bicyclic cyclohexylamines and their use as NMDA receptor antagonistsWARNER LAMBERT CO·Filed 2001·Granted Jan 27, 2004·0 cites·25 claims
- 2339US6919377B2Cyclohexylamine derivative as subtype selective NMDA receptor antagonistsWARNER LAMBERT CO·Filed 2001·Granted Jul 19, 2005·0 cites·10 claims
- 2439US6191134B1Amide derivatives of substituted quinoxaline 2, 3-diones as glutamate receptor antagonistsWARNER LAMBERT CO·Filed 1997·Granted Feb 20, 2001·1 cites·9 claims
- 2538US6110911ACyclic amine derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonistsWARNER LAMBERT CO·Filed 1999·Granted Aug 29, 2000·1 cites·1 claims
- 2636US6395930B1Quenching reagents for solution phase synthesisWARNER LAMBERT CO·Filed 2000·Granted May 28, 2002·0 cites·3 claims
- 2736US2004138230A1Heterocyclic substituted piperazines for the treatment of schizophreniaFiled 2003·Application pending·0 cites
- 2832US5484930AChiral ethyl [6-amino-4-[[12-(methoxymethylamino)-1-methyl-2-oxoethyl]amino]-5-nitro-2-pyridyl]carbamateWARNER LAMBERT CO·Filed 1995·Granted Jan 16, 1996·0 cites·2 claims
- 2930US6063774ATricyclic quinoxaline derivatives as neuroprotective agentsWARNER LAMBERT CO·Filed 1997·Granted May 16, 2000·0 cites·8 claims
Join the waitlist — get patent alerts
Get an alert when Sham Nikam files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →